PHENOBARBITAL INDUCIBLE UDP-GLUCURONOSYLTRANSFERASE IS RESPONSIBLE FOR GLUCURONIDATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE - CHARACTERIZATION OF THE ENZYME IN HUMAN AND RAT-LIVER MICROSOMES

被引:49
作者
HAUMONT, M
MAGDALOU, J
LAFAURIE, C
ZIEGLER, JM
SIEST, G
COLIN, JN
机构
[1] FAC SCI PHARMACEUT & BIOL NANCY,CTR MEDICAMENT,CNRS,URA 597,30 RUE LIONNOIS,F-54000 NANCY,FRANCE
[2] LAB WELLCOME SA,F-75013 PARIS,FRANCE
关键词
D O I
10.1016/0003-9861(90)90442-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucuronidation by liver microsomes of 3′-azido-3′-deoxythymidine (AZT) was characterized in human and in various animal species. The glucuronide isolated by HPLC, was identified by mass spectrometry (fast atom bombardment, desorption in chemical ionization), and β-glucuronidase hydrolysis. AZT glucuronidation reaction in liver microsomes of human and monkey proceeded similarly with an apparent Vmax of 0.98 nmol/min/mg protein and apparent Km of 13 mm. Oleoyl lysophosphatidylcholine activated more than twofold the formation of the glucuronide. Human kidney microsomes could also biosynthesize AZT glucuronide, although to a lower extent (six times less than the corresponding liver). Probenecid, which is administered to AIDS patients, decreased hepatic AZT glucuronidation in vitro (I50 =1.5 mm), whereas paracetamol did not exert any effect at concentrations up to 21.5 mm. Morphine also inhibited the reaction (I50 = 2.7 mm). AZT glucuronidation presented the highest rate in human and in monkey (0.50 nmol/min/mg protein); pig and rat glucuronidated the drug two and three times less, respectively. In Gunn rat, the specific activity in liver microsomes was similar (0.18 nmol/min/mg protein) to that of the congenic normal strain; this suggests that an isozyme other than bilirubin UDP-glucuronosyltransferase catalyzed the reaction. In rats, AZT glucuronidation was stimulated fourfold by phenobarbital; 3-methylcholanthrene or clofibrate failed to increase this activity. This result was consistent with the bulkiness of the AZT molecule (thickness 6.7 Å), which is a critical structural factor for glucuronidation of the drug by phenobarbital-induced isozymes. Altogether, the results strongly indicate that UDP-glucuronosyltransferase (phenobarbital inducible forms) is responsible for AZT glucuronidation. © 1990.
引用
收藏
页码:264 / 270
页数:7
相关论文
共 28 条
  • [1] PURIFICATION OF RAT-LIVER MICROSOMAL UDP-GLUCURONYLTRANSFERASE - SEPARATION OF 2 ENZYME FORMS INDUCIBLE BY 3-METHYLCHOLANTHRENE OR PHENOBARBITAL
    BOCK, KW
    JOSTING, D
    LILIENBLUM, W
    PFEIL, H
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 98 (01): : 19 - 26
  • [2] HETEROGENEITY OF HEPATIC-MICROSOMAL UDP-GLUCURONOSYLTRANSFERASES ACTIVITIES - USE AND COMPARISON OF DIFFERENTIAL INDUCTIONS IN SOME MAMMALIAN-SPECIES .2.
    BOUTIN, JA
    ANTOINE, B
    FOURNEL, S
    SIEST, G
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1987, 87 (03): : 513 - 522
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] ELECTRONIC DESCRIPTORS IN QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS
    CARTIER, A
    RIVAIL, JL
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1987, 1 (04) : 335 - 347
  • [5] CERTAIN A, 1989, J PHARM CLIN, V8, P44
  • [6] ASSESSMENT OF THE MULDER AND VANDOORN KINETIC PROCEDURE AND RAPID CENTRIFUGAL ANALYSIS OF UDP-GLUCURONOSYLTRANSFERASE ACTIVITIES
    COLINNEIGER, A
    KAUFFMAN, I
    BOUTIN, JA
    FOURNEL, S
    SIEST, G
    BATT, AM
    MAGDALOU, J
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1984, 9 (01): : 69 - 79
  • [7] PROPERTIES OF HUMAN HEPATIC UDP-GLUCURONOSYLTRANSFERASES - RELATIONSHIP TO OTHER INDUCIBLE ENZYMES IN PATIENTS WITH CHOLESTASIS
    DRAGACCI, S
    THOMASSIN, J
    MAGDALOU, J
    ELAMRI, HS
    BOISSEL, P
    SIEST, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (05) : 485 - 491
  • [8] COMPARATIVE-STUDY OF CLOFIBRIC ACID AND BILIRUBIN GLUCURONIDATION IN HUMAN-LIVER MICROSOMES
    DRAGACCI, S
    HAMARHANSEN, C
    FOURNELGIGLEUX, S
    LAFAURIE, C
    MAGDALOU, J
    SIEST, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (22) : 3923 - 3927
  • [9] DIFFERENTIAL INDUCTION PROFILE OF DRUG-METABOLIZING-ENZYMES AFTER TREATMENT WITH HYPOLIPEMIC AGENTS
    FOURNEL, S
    MAGDALOU, J
    PINON, P
    SIEST, G
    [J]. XENOBIOTICA, 1987, 17 (04) : 445 - 457
  • [10] FOURNELGIGLEUX S, 1988, DRUG METAB DISPOS, V16, P627